Breakdown | |||||
TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
536.70M | 522.31M | 487.67M | 356.85M | 181.12M | 83.27M | Gross Profit |
118.47M | 142.50M | 131.31M | 100.95M | 63.98M | 30.81M | EBIT |
3.40M | 5.00M | -41.42M | -20.11M | -18.74M | -677.00K | EBITDA |
31.95M | 33.78M | -4.20M | -33.65M | -1.96M | 8.54M | Net Income Common Stockholders |
-6.80M | -4.34M | -39.31M | -70.85M | -35.04M | -6.35M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
1.77M | 47.98M | 30.26M | 25.28M | 14.87M | 7.57M | Total Assets |
11.11M | 246.21M | 233.40M | 274.74M | 246.22M | 69.81M | Total Debt |
19.26M | 74.61M | 72.53M | 69.88M | 55.43M | 46.97M | Net Debt |
18.19M | 27.35M | 42.41M | 44.80M | 41.41M | 39.44M | Total Liabilities |
20.77M | 100.70M | 99.73M | 112.71M | 94.21M | 58.09M | Stockholders Equity |
-9.66M | 143.27M | 131.56M | 156.35M | 147.21M | 10.17M |
Cash Flow | Free Cash Flow | ||||
18.94M | 25.80M | 14.58M | -4.56M | -13.54M | 6.08M | Operating Cash Flow |
29.36M | 35.55M | 20.66M | 4.50M | -2.83M | 8.85M | Investing Cash Flow |
-11.68M | -11.01M | -5.72M | -8.59M | -28.49M | -3.30M | Financing Cash Flow |
-13.52M | -7.72M | -9.26M | 15.17M | 37.81M | 1.17M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
58 Neutral | $230.68M | ― | -4.87% | ― | 7.84% | 82.16% | |
48 Neutral | $6.84B | 1.02 | -53.11% | 2.50% | 16.84% | 0.92% | |
47 Neutral | $347.96M | 27.10 | 4.78% | ― | 16.39% | -98.10% | |
47 Neutral | $183.01M | ― | -18.27% | ― | 7.33% | 84.41% | |
32 Underperform | $257.15M | ― | -84.50% | ― | -16.27% | 76.17% |
High Tide Inc. announced it will release its first fiscal quarter 2025 financial results on March 17, 2025. The company will host a webcast on March 18, 2025, to discuss these results and future plans, highlighting its strategic positioning in the cannabis industry. This announcement is significant for stakeholders as it provides insights into High Tide’s operational performance and future growth prospects.
High Tide Inc. is set to expand its retail footprint in Ontario with the opening of two new Canna Cabana stores in Collingwood and Cambridge. These new locations, strategically positioned to attract both local residents and tourists, will enhance the company’s market presence and accessibility to legal cannabis. The Collingwood store is located in a high-traffic area popular with tourists, while the Cambridge store benefits from a dense residential area with limited competition. This expansion marks a step towards High Tide’s milestone of 200 stores nationwide, reinforcing its commitment to providing affordable cannabis through its innovative discount club model.
High Tide Inc. has paused its acquisition of a 51% interest in Purecan GmbH, initially intended to facilitate its entry into the German medical cannabis market. The company is now exploring alternative arrangements with Purecan to maintain its planned commercial exposure in Germany, while remaining committed to finding other opportunities in the market. This strategic reassessment underscores High Tide’s dedication to expanding its presence in the international cannabis market, despite uncertainties in the current transaction.
High Tide Inc. has been recognized by the TSX Venture Exchange as one of the Top 50 companies for the second consecutive year, ranking 21st for 2024. This recognition highlights the company’s successful operations in the Canadian cannabis market and its strategic expansion into international markets such as Germany. High Tide’s Canna Cabana brand has contributed significantly to its growth, boasting over 1.7 million members in its loyalty program. The company continues to position itself as a leader in the cannabis industry by expanding its brand offerings and market reach.
High Tide has announced the opening of its 77th Canna Cabana location in Ontario, specifically in downtown Hamilton, marking its 192nd store in Canada. This expansion aligns with the company’s strategy to position its stores in high-foot-traffic areas, enhancing its presence in the Canadian cannabis retail market. Additionally, High Tide is entering the German medical cannabis market with the acquisition of Purecan, aiming to replicate its Canadian market success and become a leading distributor of Canadian medical cannabis products in Germany.
High Tide Inc. reported record annual revenue of $522.3 million for the fiscal year ending October 31, 2024, marking its sixth consecutive quarter of positive free cash flow. The company’s flagship Cabana Club loyalty program expanded significantly, reaching 5.32 million members globally. Notably, High Tide maintained its position as the leading revenue-generating cannabis company in Canada, with significant market shares in Alberta and Ontario. Despite a net loss of $3.8 million for the year, the company showed notable improvement from the previous year’s loss, highlighting a positive trajectory in financial performance. High Tide’s annualized retail sales per square foot surpassed that of top retailers like Wal-Mart and Target, demonstrating strong operational efficiency.
High Tide Inc. announced it will release its fourth fiscal quarter and full fiscal year 2024 financial results on January 29, 2025. Following the release, a webcast will be hosted by the company’s CEO and CFO to discuss these results and future plans. This announcement is crucial for stakeholders as it provides insights into the company’s financial health and strategic direction, potentially impacting its industry positioning and investor confidence.
High Tide Inc. is expanding into the German medical cannabis market by acquiring a 51% stake in Purecan GmbH, a profitable pharmaceutical wholesaler with an import license and logistics infrastructure in Germany, for approximately €4.8 million. This strategic acquisition allows High Tide to leverage its Canadian procurement expertise and establish itself as a leading supplier in a rapidly growing market, positioning the company for further expansion into other European markets. The acquisition is expected to bolster High Tide’s market presence and strengthen its international business lines, while Purecan benefits from High Tide’s established procurement networks, addressing the rising demand for medical cannabis in Germany.